Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.

Schrörs B, Lübcke S, Lennerz V, Fatho M, Bicker A, Wölfel C, Derigs P, Hankeln T, Schadendorf D, Paschen A, Wölfel T.

Oncotarget. 2017 Apr 25;8(17):28312-28327. doi: 10.18632/oncotarget.16048.

2.

[Diagnosis and treatment of diving accidents. New German guidelines for diving accidents 2014-2017].

Jüttner B, Wölfel C, Liedtke H, Meyne K, Werr H, Bräuer T, Kemmerer M, Schmeißer G, Piepho T, Müller O, Schöppenthau H; German Society for Diving and Hyperbaric Medicine; Swiss Underwater and Hyperbaric Medical; German Interdisciplinary Association for Intensive Care and Emergency Medicine; Naval Medical Institute; Sports Divers Association; Social Accident Insurance Institution for the Building Trade; Association of Hyperbaric Treatment Centers; Society of Occupational and Environmental Medicine.

Anaesthesist. 2015 Jun;64(6):463-8. doi: 10.1007/s00101-015-0033-7. German.

PMID:
26025255
3.

Distinct signaling cascades of TREM-1, TLR and NLR in neutrophils and monocytic cells.

Prüfer S, Weber M, Sasca D, Teschner D, Wölfel C, Stein P, Stassen M, Schild H, Radsak MP.

J Innate Immun. 2014;6(3):339-52. doi: 10.1159/000355892. Epub 2013 Nov 21.

4.

Anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer (NSCLC): results of a multi-centre ALK-testing.

V Laffert M, Warth A, Penzel R, Schirmacher P, Jonigk D, Kreipe H, Schildhaus HU, Merkelbach-Bruse S, Büttner R, Reu S, Kerler R, Jung A, Kirchner T, Wölfel C, Petersen I, Rodriguez R, Jochum W, Bartsch H, Fisseler-Eckhoff A, Berg E, Lenze D, Dietel M, Hummel M.

Lung Cancer. 2013 Aug;81(2):200-6. doi: 10.1016/j.lungcan.2013.04.015. Epub 2013 May 10.

PMID:
23669200
5.

Telemedicine in the management of diving accidents: correlation of phone-assessed symptom severity with clinical findings.

Wölfel C, Schüpfer G, Konrad C, Knessl P, Wendling J.

Diving Hyperb Med. 2011 Dec;41(4):189-94.

PMID:
22183695
6.

Problems of a preclinical treatment algorithm for diving accidents: analysis of the Swiss hyperbaric situation.

Wendling J, Nussberger P, Wölfel C.

Diving Hyperb Med. 2009 Jun;39(2):100-3.

PMID:
22753203
7.

Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia.

Tschiedel S, Gentilini C, Lange T, Wölfel C, Wölfel T, Lennerz V, Stevanovic S, Rammensee HG, Huber C, Cross M, Niederwieser D.

Leukemia. 2008 Aug;22(8):1542-50. doi: 10.1038/leu.2008.107. Epub 2008 May 22.

PMID:
18496563
8.

Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.

Distler E, Wölfel C, Köhler S, Nonn M, Kaus N, Schnürer E, Meyer RG, Wehler TC, Huber C, Wölfel T, Hartwig UF, Herr W.

Exp Hematol. 2008 Apr;36(4):451-63. doi: 10.1016/j.exphem.2007.12.011. Epub 2008 Feb 8.

PMID:
18261837
9.

Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation.

Wölfel C, Lennerz V, Lindemann E, Hess G, Derigs HG, Huber C, Herr W, Wölfel T.

Cancer Immunol Immunother. 2008 Jun;57(6):849-57. Epub 2007 Nov 15.

PMID:
18004563
10.

An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression.

Marques CA, Hähnel PS, Wölfel C, Thaler S, Huber C, Theobald M, Schuler M.

Blood. 2008 Feb 1;111(3):1413-9. Epub 2007 Oct 30.

PMID:
17971488
11.

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens.

Lennerz V, Fatho M, Gentilini C, Frye RA, Lifke A, Ferel D, Wölfel C, Huber C, Wölfel T.

Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16013-8. Epub 2005 Oct 24.

12.

CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression.

Dörrschuck A, Schmidt A, Schnürer E, Glückmann M, Albrecht C, Wölfel C, Lennerz V, Lifke A, Di Natale C, Ranieri E, Gesualdo L, Huber C, Karas M, Wölfel T, Herr W.

Blood. 2004 Oct 15;104(8):2591-9. Epub 2004 Jul 1.

PMID:
15231579
13.

Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope.

Wölfel C, Drexler I, Van Pel A, Thres T, Leister N, Herr W, Sutter G, Huber C, Wölfel T.

Int J Cancer. 2000 Nov 1;88(3):432-8.

14.

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.

Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde KH, Beach D.

Science. 1995 Sep 1;269(5228):1281-4.

PMID:
7652577
15.

The cytotoxicity of mitomycin C and adriamycin in genetically engineered V79 cell lines and freshly isolated rat hepatocytes.

Goeptar AR, te Koppele JM, Glatt HR, Groot EJ, Seidel A, Barrenscheen M, Wölfel C, Doehmer J, Vermeulen NP.

Chem Biol Interact. 1995 Jul 14;97(2):149-68.

PMID:
7606813
16.

Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.

Bernhard H, Karbach J, Wölfel T, Busch P, Störkel S, Stöckle M, Wölfel C, Seliger B, Huber C, Meyer zum Büschenfelde KH, et al.

Int J Cancer. 1994 Dec 15;59(6):837-42.

PMID:
7989126
18.

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Brichard V, Van Pel A, Wölfel T, Wölfel C, De Plaen E, Lethé B, Coulie P, Boon T.

J Exp Med. 1993 Aug 1;178(2):489-95.

19.

Genetically engineered V79 Chinese hamster cells for stable expression of human cytochrome P450IA2.

Wölfel C, Heinrich-Hirsch B, Schulz-Schalge T, Seidel A, Frank H, Ramp U, Wächter F, Wiebel FJ, Gonzalez F, Greim H, et al.

Eur J Pharmacol. 1992 Sep 1;228(2-3):95-102.

PMID:
1446722
20.

Applications of stable V79-derived cell lines expressing rat cytochromes P4501A1, 1A2, and 2B1.

Doehmer J, Wölfel C, Dogra S, Doehmer C, Seidel A, Platt KL, Oesch F, Glatt HR.

Xenobiotica. 1992 Sep-Oct;22(9-10):1093-9.

PMID:
1441600
21.

Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms.

Fuhr U, Doehmer J, Battula N, Wölfel C, Kudla C, Keita Y, Staib AH.

Biochem Pharmacol. 1992 Jan 22;43(2):225-35.

PMID:
1739411
22.

The use of genetically engineered V79 Chinese hamster cultures expressing rat liver CYP1A1, 1A2 and 2B1 cDNAs in micronucleus assays.

Ellard S, Mohammed Y, Dogra S, Wölfel C, Doehmer J, Parry JM.

Mutagenesis. 1991 Nov;6(6):461-70.

PMID:
1800893
23.

[Genetically engineered V79 Chinese hamster cells for stable expression of xenobiotics metabolising enzymes]

Doehmer J, Barrenscheen M, Dogra S, Edigkaufer M, Giatt H, Oesch F, Platt KL, Seidel A, Wölfel C.

ALTEX. 1991;8(2):52-65.

PMID:
11178563
24.

Stable expression of rat cytochrome P450IA2 cDNA and hydroxylation of 17 beta-estradiol and 2-aminofluorene in V79 Chinese hamster cells.

Wölfel C, Platt KL, Dogra S, Glatt H, Wächter F, Doehmer J.

Mol Carcinog. 1991;4(6):489-98.

PMID:
1793487

Supplemental Content

Loading ...
Support Center